“…However, in the HLA-A-Bw4/KIR3DL1 interaction, other amino acid residues within and outside the Bw4 motif sequence also play a role; as Saunders et al 2021 write, “differential recognition across HLA-Bw4 allotypes is therefore likely a product of polymorphic residues in both the a1 and a2 domains, differences in peptide repertoire and conformation, as well as KIR3DL1 allotype” [ 39 ]. The inhibitory KIR3DL1 is one of the most polymorphic alleles of all the KIR loci and is divided into three allotype groups: KIR3DL1Null (*004, *019), which show no expression at the cell surface, KIR3DL1Low (*005, *007) showing low expression, and KIR3DL1High (*001, *002, *008, *009, *015, *020) exhibiting high expression at the cell surface [ 28 , 29 , 44 , 45 ]. However, our test did not differentiate exactly between these groups, particularly between KIR3DL1Null and KIR3DL1Low, dividing KIR3DL1 into two groups only.…”